Successful treatment of steroid-refractory gastrointestinal acute graft-versus-host disease with adjuvant vedolizumab therapy in a pediatric allogeneic stem cell transplant recipient

被引:5
|
作者
Pai, Vinita [1 ,2 ]
Abu-Arja, Rolla [3 ,4 ]
Auletta, Jeffery J. [3 ,4 ]
Rangarajan, Hemalatha G. [3 ,4 ]
机构
[1] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
[2] Nationwide Childrens Hosp, Pharm Dept, Columbus, OH USA
[3] Nationwide Childrens Hosp, Div Hematol Oncol Blood & Marrow Transplant, 700 Childrens Dr, Columbus, OH 43205 USA
[4] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
关键词
D O I
10.1002/pbc.28298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
    Kyohei Isshiki
    Takahiro Kamiya
    Akifumi Endo
    Kentaro Okamoto
    Tomoo Osumi
    Toshinao Kawai
    Katsuhiro Arai
    Daisuke Tomizawa
    Kazuo Ohtsuka
    Masakazu Nagahori
    Kohsuke Imai
    Motohiro Kato
    Hirokazu Kanegane
    International Journal of Hematology, 2022, 115 : 590 - 594
  • [2] Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
    Isshiki, Kyohei
    Kamiya, Takahiro
    Endo, Akifumi
    Okamoto, Kentaro
    Osumi, Tomoo
    Kawai, Toshinao
    Arai, Katsuhiro
    Tomizawa, Daisuke
    Ohtsuka, Kazuo
    Nagahori, Masakazu
    Imai, Kohsuke
    Kato, Motohiro
    Kanegane, Hirokazu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 590 - 594
  • [3] Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease
    Alexander Coltoff
    Guido Lancman
    Sara Kim
    Amir Steinberg
    Bone Marrow Transplantation, 2018, 53 : 900 - 904
  • [4] Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease
    Coltoff, Alexander
    Lancman, Guido
    Kim, Sara
    Steinberg, Amir
    BONE MARROW TRANSPLANTATION, 2018, 53 (07) : 900 - 904
  • [5] Infliximab for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in allogeneic stem cell transplant patients
    Rajpal, R
    Vandenberghe, E
    Browne, P
    Mccann, S
    King, F
    Conneally, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 113 - 113
  • [6] Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients
    Khandelwal, Pooja
    Teusink-Cross, Ashley
    Davies, Stella M.
    Nelson, Adam S.
    Dandoy, Christopher E.
    El-Bietar, Javier
    Marsh, Rebecca A.
    Kumar, Ashish R.
    Grimley, Michael S.
    Jodele, Sonata
    Myers, Kasiani C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1122 - 1127
  • [7] Vedolizumab for second-line treatment of steroid-refractory gastrointestinal late acute graft-versus-host disease
    Zu, Yingling
    Gui, Ruirui
    Li, Zhen
    Wang, Juan
    Li, Pei
    Liu, Ying
    Dong, Xiaofeng
    Zhou, Jian
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [8] Vedolizumab for Treatment of Steroid-Refractory Lower Gastrointestinal Acute Graft-Versus-Host Disease-a Quality Initiative
    Coltoffi, Alexander
    Lancman, Guido
    Kim, Sara
    Steinberg, Amir
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S201 - S201
  • [9] The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients
    Khandelwal, Pooja
    Lawrence, Julia
    Filipovich, Alexandra H.
    Davies, Stella M.
    Bleesing, Jacob J.
    Jordan, Michael B.
    Mehta, Parinda
    Jodele, Sonata
    Grimley, Michael S.
    Kumar, Ashish
    Myers, Kasiani
    Marsh, Rebecca A.
    PEDIATRIC TRANSPLANTATION, 2014, 18 (01) : 94 - 102
  • [10] Etanercept as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients
    Faraci, Maura
    Calevo, Maria Grazia
    Giardino, Stefano
    Leoni, Massimiliano
    Ricci, Erica
    Castagnola, Elio
    Lanino, Edoardo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 743 - 748